Thaçi, D., Pinter, A., Sebastian, M., Termeer, C., Sticherling, M., Gerdes, S., . . . Eyerich, K. (2024). Guselkumab demonstrates long-term efficacy and maintenance of treatment response postwithdrawal in systemic treatment-naïve patients and nonresponders to fumaric acid esters: Results from parts II and III of a randomized active-comparator-controlled phase IIIb trial (POLARIS). British journal of dermatology, 191(1), . https://doi.org/10.1093/bjd/ljad523
Chicago-Zitierstil (17. Ausg.)Thaçi, Diamant, et al. "Guselkumab Demonstrates Long-term Efficacy and Maintenance of Treatment Response Postwithdrawal in Systemic Treatment-naïve Patients and Nonresponders to Fumaric Acid Esters: Results from Parts II and III of a Randomized Active-comparator-controlled Phase IIIb Trial (POLARIS)." British Journal of Dermatology 191, no. 1 (2024). https://doi.org/10.1093/bjd/ljad523.
MLA-Zitierstil (9. Ausg.)Thaçi, Diamant, et al. "Guselkumab Demonstrates Long-term Efficacy and Maintenance of Treatment Response Postwithdrawal in Systemic Treatment-naïve Patients and Nonresponders to Fumaric Acid Esters: Results from Parts II and III of a Randomized Active-comparator-controlled Phase IIIb Trial (POLARIS)." British Journal of Dermatology, vol. 191, no. 1, 2024, https://doi.org/10.1093/bjd/ljad523.